ArticleJournal of clinical medicine2019

Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.

Marina Silvia Parisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.